mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
HL

Haleos Labs Limited

NSE:HALEOSLABSBSE:HALEOSLABS
HealthcarePharmaceuticals & Biotechnology
₹1,490.0
-0.76%1 Oct close
Mkt cap
₹447 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
AnnualQuarterly
ConsolidatedStandalone

Consolidated figures · ₹ crore

₹ CrMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
261266350316306345334
COGS158137195171151154139
Gross profit103129155144155191195
7898121115124146151
25303429314545
OPM %9.7%11.4%9.8%9.1%10.2%13.1%13.4%
Depreciation881011151515
Interest55671096
22155452
Profit before tax15203317102625
Tax4675477
Tax %30.5%30.7%22.7%31.5%35.7%28.5%29.4%
1014251161918
PAT margin %3.9%5.1%7.2%3.6%2.1%5.4%5.3%
EPS (₹)33.744.883.737.930.166.557.3
EPS adjusted (₹)—44.983.73830.166.657.3
0%3.3%1.8%4%5%2.3%2.6%
Annual reportAnnual report for Mar 2020Annual report for Mar 2021Annual report for Mar 2022Annual report for Mar 2023Annual report for Mar 2024Annual report for Mar 2025—

₹ CrMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital333333
Reserves126149166174194211
Minority interest01320171516
5977999884109
1141151089994116
Total equity & liabilities302357395391390454
129140227221230267
CWIP385116010
Investments000000
135166167164159177
Total assets302357395391390454

₹ CrMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
301535-1115243437
-44-27-26-7-31-18-15-58
1512-31117-7-1921
Net cash flow1-06-80-1-01
Free cash flow——-0-62-34319-21
CFO / Operating profit %—57.3%116.6%-32.9%51.1%78.1%75.6%83.3%

Compounded sales growth

7 years
—
5 years
5%
3 years
2%
1 year
-3%

Compounded profit growth

7 years
—
5 years
6%
3 years
16%
1 year
-5%

Stock price CAGR

10 years
—
5 years
16%
3 years
42%
1 year
23%

Return on equity

7 years
—
5 years
8%
3 years
7%
Last year
8%